Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost-effectiveness model.

Sameera Ezzat Ivane Gamkrelidze Alaa Osman Asmaa I Gomaa Ayat Roushdy Gamal Esmat Homie Razavi Sarah Blach Wael Abdel-Razek Wafaa El-Akel Imam Waked

Published in: Liver international : official journal of the International Association for the Study of the Liver (2023)

The national screening and treatment programme is highly cost-effective by the year 2021, cost-saving by 2029 and expected to save about $35 million in direct costs and $4705 million in indirect costs by 2030.

Keyphrases

quality improvement